Daratumumab/rituximabHypogammaglobulinaemia, infections and systemic infections: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1616卷 / 1期

关键词：

D O I：

10.1007/s40278-016-20678-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：61 / 61

相关论文

共 50 条

[21] Dasatinib/imatinibOpportunistic infections: 2 case reports
Reactions Weekly, 2010, 1318 (1) : 18 - 18
[22] RituximabSinus and pulmonary infections: 2 case reports
Reactions Weekly, 2017, 1656 (1) : 404 - 404
[23] AntineoplasticsFatal septic infections: 2 case reports
Reactions Weekly, 2012, 1391 (1) : 9 - 9
[24] RituximabHypogammaglobulinaemia: 5 case reports
Reactions Weekly, 2021, 1877 (1) : 350 - 350
[25] ObinutuzumabInvasive fungal infections: 2 case reports
Reactions Weekly, 2015, 1547 (1) : 206 - 206
[26] TacrolimusAllergy and minor infections: 2 case reports
Reactions Weekly, 2018, 1685 (1) : 191 - 191
[27] RituximabHypogammaglobulinaemia: 3 case reports
Reactions Weekly, 2010, 1332 (1) : 37 - 37
[28] RituximabCytomegalovirus infections and respiratory infections: 6 case reports
Reactions Weekly, 2020, 1828 (1) : 453 - 453
[29] RituximabHypogammaglobulinaemia and neutropenia: 4 case reports
Reactions Weekly, 2019, 1738 (1) : 232 - 232
[30] ImmunosuppressantsInvasive Rhodococcus equi infections: 2 case reports
Reactions Weekly, 2011, 1334 (1) : 27 - 27

← 1 2 3 4 5 →